G91905FJ

Summary
GlyTouCan ID
G91905FJ
IUPAC Condensed
Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc(b1-
Motifs
N-Glycan complex Polysialic acid
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
2733.97
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
CarbBank
27285
KEGG BRITE Database
KEGG ID
GALAXY
Glucose Units
ODS
12.6
Amide
7.6
Degrading Enzymes
Displaying all 3 entries
Enzyme Substrate Product
α-Fucosidase
G91905FJ
G99074EO
α-Sialidase
G91905FJ
G45359RY
β-Galactosidase
G91905FJ
G72578SV
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:b-dglc-HEX-1:5
8s:n-acetyl
9b:b-dgal-HEX-1:5
10b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
11s:n-acetyl
12b:a-dman-HEX-1:5
13b:b-dglc-HEX-1:5
14s:n-acetyl
15b:b-dgal-HEX-1:5
16b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
17s:n-acetyl
18b:b-dglc-HEX-1:5
19s:n-acetyl
20b:b-dgal-HEX-1:5
21b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7d(2+1)8n
8:7o(4+1)9d
9:9o(3+2)10d
10:10d(5+1)11n
11:5o(6+1)12d
12:12o(2+1)13d
13:13d(2+1)14n
14:13o(4+1)15d
15:15o(3+2)16d
16:16d(5+1)17n
17:12o(6+1)18d
18:18d(2+1)19n
19:18o(4+1)20d
20:1o(6+1)21d
WURCS
WURCS=2.0/6,14,13/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O][a1221m-1a_1-5]/1-1-2-3-1-4-5-3-1-4-5-1-4-6/a4-b1_a6-n1_b4-c1_c3-d1_c6-h1_d2-e1_e4-f1_f3-g2_h2-i1_h6-l1_i4-j1_j3-k2_l4-m1
Literature
Displaying entries 1 - 10 of 13 in total
PubMed ID Title First Author Publication Date Source
11805077 Structural analysis of sulfated N-linked oligosaccharides in erythropoietin Kawasaki N 2001 Dec
  • GlyGen
  • PubChem
10764840 Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties Cointe D 2000 May
  • GlyGen
  • PubChem
8687384 The glycosylation of Bowes melanoma tissue plasminogen activator: lectin mapping, reaction with anti-L2/HNK-1 antibodies and the presence of sulphated/glucuronic acid containing glycans Jaques AJ 1996 Jun 01
  • GlyGen
  • PubChem
8620897 Detailed oligosaccharide structures of human integrin alpha 5 beta 1 analyzed by a three-dimensional mapping technique Nakagawa H 1996 Apr 01
  • GlyGen
  • PubChem
7737204 Structural Analysis of the Sialylated N- and O-Linked Carbohydrate Chains of Recombinant Human Erythropoietin Expressed in Chinese Hamster Ovary Cells. Sialylation Patterns and Branch Location of Dimeric N-acetyllactosamine Units Hokke CH 1995 Mar 15
  • GlyGen
  • PubChem
8462541 Primary structure of N-linked carbohydrate chains of a human chimeric plasminogen activator K2tu-PA expressed in Chinese hamster ovary cells BERGWERFF AA 1993 Mar 15
  • GlyGen
  • PubChem
8460945 Structures of Mucin-Type Sugar Chains on Human Erythropoietins Purified from Urine and the Culture Medium of Recombinant Chinese Hamster Ovary Cells Inoue N 1993 Mar
  • GlyGen
  • PubChem
8477709 Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK-21 cells NIMTZ M 1993 Apr 01
  • GlyGen
  • PubChem
2226797 Carbohydrate structures of a human tissue plasminogen activator variant expressed in recombinant Chinese hamster ovary cells Nimtz M 1990 Oct 01
  • GlyGen
  • PubChem
2813359 Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells Takeuchi M 1989 Oct
  • GlyGen
  • PubChem

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025